Fill out the form on the right to download the whitepaper →
Around 30% of pharmacovigilance literature review references are duplicates. This costs pharmaceuticals time and money.
Our whitepaper Finding the One can help you do something about it. Fill out the form to get the whitepaper and you'll learn:
→ Why duplicates are one of the biggest sources of inefficiency in your medical literature monitoring process
→ The regulatory and compliance risks that can be caused by processing too many duplicate references
→ The best practices drug safety teams should follow to reduce duplicate literature references